NP / PA
Maltman Medical Center LLC
Maltman Medical Center LLC was paid $2.72M by Medicaid between Jan 2018 and Dec 2024, across 51 billing codes. Its largest line is J2315, Injection, naltrexone, depot form, 1 mg — 36% of everything it billed.
33Billing provider infoMALTMAN MEDICAL CENTER LLC
KNOXVILLE, TN 37923
KNOXVILLE, TN 37923
33aNPI1225586878assigned 09/12/2016
33bProvider typeNurse Practitioner
28Total paid$2.72M
24GClaims91,564
24DCodes billed51
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Tennessee
Rank by total paid#4 of 212
Median peer was paid$17K
This provider vs. median162×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,758 | $468K | |
| 2019 | 14,327 | $592K | |
| 2020 | 9,845 | $437K | |
| 2021 | 12,845 | $317K | |
| 2022 | 18,213 | $343K | |
| 2023 | 15,579 | $343K | |
| 2024incomplete | 9,997 | $220K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2315 | Injection, naltrexone, depot form, 1 mg | 36% | 1,932 | 1,299 | $982K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 17,744 | 12,378 | $812K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.6% | 2,896 | 2,347 | $233K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.3% | 3,563 | 2,862 | $117K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 3.7% | 1,602 | 1,318 | $100K |
| 96160 | 2.2% | 6,134 | 4,141 | $59K | |
| 81025 | 1.6% | 10,326 | 7,264 | $43K | |
| 99406 | 1.5% | 6,603 | 4,764 | $41K | |
| 80305 | 1.3% | 7,237 | 5,094 | $36K | |
| G0444 | Annual depression screening, 5 to 15 minutes | 1.2% | 4,333 | 3,470 | $32K |
| 93000 | 1.2% | 2,760 | 2,202 | $31K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 2,823 | 1,799 | $30K |
39 more codes
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.1% | 507 | $30K |
| 94010 | 1.1% | 1,533 | $30K | |
| 99401 | 1.0% | 1,963 | $27K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 3,296 | $17K |
| 81002 | <1% | 7,492 | $13K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 393 | $13K |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | <1% | 417 | $11K |
| 99408 | <1% | 681 | $11K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 72 | $8K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 320 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,299 | $5K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 360 | $4K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 100 | $3K |
| 90674 | <1% | 142 | $3K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 31 | $2K |
| 3008F | <1% | 720 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 121 | $2K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 60 | $2K |
| 99173 | <1% | 346 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 206 | $1K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 14 | $1K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 63 | $977.39 |
| 90686 | <1% | 151 | $952.60 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 22 | $923.06 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 38 | $770.52 |
| 99326 | <1% | 21 | $544.12 | |
| 90688 | <1% | 38 | $539.23 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 44 | $422.32 |
| 90685 | <1% | 36 | $327.43 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 32 | $303.14 |
| 87210 | <1% | 94 | $241.83 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 178 | $221.20 |
| 98960 | <1% | 13 | $115.69 | |
| 82948 | <1% | 49 | $102.23 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 178 | $60.71 |
| 82962 | <1% | 13 | $31.72 | |
| M1207 | Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety | 0% | 494 | $0.00 |
| 99000 | 0% | 52 | $0.00 | |
| 99072 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMALTMAN, STACEY (PRESIDENT)